Clinical Trial Update: Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates sunitinib given before and during radiotherapy in patients with newly diagnosed biopsy-only glioblastoma. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Sunitinib (sunitinib)

Snippet

Sponsor: Grupo Español de Investigación en Neurooncología | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED